Science Explorer Interactive view Map
Company · Boston · ??

Insilico Medicine (United States)

insilico.comROR OpenAlex
Research works
17
▲ 880% vs 2013–17
Citations
639
38.2 per fractional work
Top-10% rate
55.0%
record average 16.5%
Open access
64%
world 28%

Not ranked overall: Insilico Medicine (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 7.97× its world share, 4 worksBiochemistry, Geneti…Immunology and Microbiology: 1.84× its world share, 0 worksImmunology and Micro…Neuroscience: 1.18× its world share, 0 worksNeuroscienceChemistry: 3.93× its world share, 1 worksChemistryComputer Science: 0.52× its world share, 0 worksComputer ScienceEngineering: 0.16× its world share, 0 worksEngineeringMaterials Science: 1.15× its world share, 0 worksMaterials ScienceMedicine: 1.69× its world share, 3 worksMedicinePsychology: 1.21× its world share, 0 worksPsychologySocial Sciences: 0.07× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 8.0×. Every wedge is a field page.

Which research topics does Insilico Medicine (United States) publish most on?

By volume in 2022–2025: Fibroblast Growth Factor Research, Advanced Breast Cancer Therapies, Mechanisms of cancer metastasis and Protein Kinase Regulation and GTPase Signaling.

Fibroblast Growth Factor…1Fibroblast Growth Factor Research: 1 fractional worksAdvanced Breast Cancer T…0Advanced Breast Cancer Therapies: 0 fractional worksMechanisms of cancer met…0Mechanisms of cancer metastasis: 0 fractional worksProtein Kinase Regulatio…0Protein Kinase Regulation and GTPase Signaling: 0 fractional worksMachine Learning in Materials Science: 0 fractional worksEpigenetics and DNA Methylation: 0 fractional worksLung Cancer Treatments a…0Lung Cancer Treatments and Mutations: 0 fractional worksPARP inhibition in cancer therapy: 0 fractional worksKruppel-like factors research: 0 fractional worksEosinophilic Disorders a…0Eosinophilic Disorders and Syndromes: 0 fractional works
Molecular BiologyPulmonary and Respiratory MedicineMaterials ChemistryOncology1 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Fibroblast Growth Factor Research Molecular Biology 1 works
  2. 2 Advanced Breast Cancer Therapies Pulmonary and Respiratory Medicine 0 works
  3. 3 Mechanisms of cancer metastasis Molecular Biology 0 works
  4. 4 Protein Kinase Regulation and GTPase Signaling Molecular Biology 0 works
  5. 5 Machine Learning in Materials Science Materials Chemistry 0 works
  6. 6 Epigenetics and DNA Methylation Molecular Biology 0 works
  7. 7 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 0 works
  8. 8 PARP inhibition in cancer therapy Oncology 0 works
  9. 9 Kruppel-like factors research Molecular Biology 0 works
  10. 10 Eosinophilic Disorders and Syndromes Rheumatology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available64.1%not open35.9%

World: 28% of research is openly available.

with international co-authors32.0%domestic only68.0%

World: 19% is written across borders.

How has Insilico Medicine (United States)'s research output changed?

Output in 2018–2022 was 880% higher than in 2013–2017.

2020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Boston

All research institutions in Boston

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.